Aripiprazole-Induced Raynaud's Phenomenon: An Adolescent Case

Camkurt, Mehmet Akif; Güneş, Serkan; Tecimer, Ergün

doi:10.1089/cap.2015.0153

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2018

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another case presentation, Camkurt et al . 9) reported a case of RP with aripiprazole which is an atypical antipsychotic with a partial agonism for D 2 and 5HT 1a receptors, and an antagonism for 5HT 2a . In this paper, it was suggested that RP could be associated with dopaminergic agonism or serotonergic effects of aripiprazole.…”

Section: Discussionmentioning

confidence: 99%

Risperidone Related Raynaud's Phenomenon: An Adolescent Case

Güneş¹,

Ekinci

Teke

et al. 2018

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

Raynaud’s phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud’s phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud’s phenomenon associated with risperidone in a 12-year-old boy. Raynaud’s phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.

show abstract

Section: Discussionmentioning

confidence: 99%